GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) are prescribed for type 2 diabetes and weight management in the UK
Zhang Q, Li Q, Liu S, Zheng H, Ji L, Yi N et al (2022) Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia
Avoid artificial sweeteners Sugar substitutes are often present in foods promoted for weight loss
Cross-Indication Pricing Implications With GLP-1 therapies spanning multiple indications, cross-indication pricing poses a strategic challenge
Endocrinol Diabetes Metab (2020) 3(3):e00163
What makes it stand out nutritionally is its unmatched density of vitamins, minerals, antioxidants, and essential amino acids